Patent Litigation in the Pharmaceutical and Biotechnology Industries (Pharma, Biotech and Bioscience: Science, Technology and Business)

Written by a leading practitioner in the field, this book focuses on the key subject of multi-jurisdictional patent litigation strategies and product lifecycle management in the pharmaceutical and biotechnology industries. This book therefore looks at the characteristics and strategies typically employed in fighting multi-jurisdictional litigation within these industries. In particular, patentability and the enforceability of biotechnological inventions are examined as they remain one of the most fluid, commercially important and emotive topics in the patent industry. The book reviews the current position as regards these issues in the biotechnology industries and report on likely key developments: such as the US gene patent litigation brought to block gene patents in principle and also the reference currently pending before the Court of Justice in Europe that will determine the scope of protection provided under Article 9 Biotechnology Directive in relation to DNA-based patent claims. This title provides in-house counsel with a guide to strategic multi-jurisdictional litigation within the pharmaceutical and biotechnology industries. It highlights how best to integrate the patent and medicinal regulatory aspects of product development and lifecycle management. It also provides institutional investors with an insight into the unique considerations behind enforcing intellectual property in the pharmaceutical and biotechnology fields. It reviews recent developments concerning the patentability and enforceability of biotechnology patents, both in the EU and US. It provides insight and opinion regarding the future of patent litigation in the EU. Other texts may be able to provide one or two of the above aspects but, until this book, no text has combined all. This combination appeals both to practitioners, investors and legal students.